Cite

HARVARD Citation

    Raldow, A. et al. (2020). Cost Effectiveness of DCISionRT for Guiding Treatment of Ductal Carcinoma in Situ. JNCI cancer spectrum. 4 (2), p. . [Online]. 
  
Back to record